12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Ablynx, Merck deal

Ablynx partnered with Merck to develop and commercialize Ablynx's Nanobodies targeting an undisclosed voltage-gated ion channel. The deal includes an option to develop and commercialize a Nanobody against a...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >